A compound of general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating kinase-associated disease states using the compound of formula (I) is also described. ##STR00001##

 
Web www.patentalert.com

< Pyrimidine derivatives for inhibiting Eph receptors

< Use of IRS-polypeptides for identifying of pharmaceutically active compounds

> Pyridazinone derivatives, methods for their production and their use as pharmaceuticals

> 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
~ 00615